Jul 3, 2023

Company maintains focus to work closely with innovative firms to design, build, implement, and maintain automation solutions in high-precision applications. Michael Barbella, Managing Editor07.03.23 Formed through the combination of Eckhart Inc. and Innovative Products & Equipment Inc., Invio Automation provides high-value solutions to help customers accelerate growth in specialized markets including medical device, life sciences, and advanced manufacturing. "We see tremendous opportunity in the market to support our customers' growth objectives with our world-class, integrated team and decades of experience delivering proven automation solutions," Invio CEO Andy Storm said. "We will continue to invest in our position as a trusted partner to global companies, executing at each important stage of the automation journey." With its scaled engineering resources and end-to-end expertise in complex automation, the company aims to serve a targeted portfolio of growth markets supported by recognized and sustainable macro tailwinds. Invio works closely with companies to design, build, implement, and maintain automation solutions in high-precision applications, leveraging a design library and more than 500 experienced team members across nine sites in North America and a global network of collaborative partners. "We are taking a market-first approach to building the Invio platform. Our significant focus and right to win in high-value medical device, life sciences, renewable energy, and other advanced manufacturing applications will result in a more scalable, effective, and forward-thinking solutions provider," Arsenal Operating Partner Sal Gagliardo stated. Invio's full suite of capabilities support initial automation and process development concepts, leveraging Factory of the Future (design and simulation) services, through the implementation of fully automated systems including test, validation, and analytics tools. Invio enhances custom automation solutions with proprietary Autonomous Guided Vehicles (AGVs), Autonomous Mobile Robots (AMRs), semi-automated tooling, and other advanced automation technologies focused on enabling efficient material flow. Invio's design, execution, maintenance, and support drives ongoing, high ROI customer relationships and creates revenue opportunities for customers through automation in addition to increased operational efficiency and improved safety. "Invio Automation's scale, internal processes, unique automation capabilities, and integration expertise represent a high value proposition to both customers and potential M&A partners focused on accelerating organic growth," Arsenal Principal Robert Sorrel said. Invio Automation is an Industry 4.0 leader that designs, builds, implements, and sustains high-value automation solutions, with a focus on helping customers accelerate growth in specialized markets including medical device, life sciences, and advanced manufacturing. Invio uses domain expertise and extensive engineering capabilities to partner with customers globally from product design and R&D pre-validation through full automation in high growth applications. Invio customers value high precision, quality, efficiency, and safety and rely on innovative and scalable solutions and support from Invio to accelerate organic growth opportunities. Invio Automation's Solutions division specializes in single station robotic cells, multi-station fabrication and assembly lines, bonding and welding technologies, vision systems, and packaging processes. Solutions capabilities include thermal bonding, web handling, force plotting, heat staking, high viscosity pumps, precision dispensing, impulse bag sealing, and needle bending. Arsenal Capital Partners is a private equity firm that specializes in investments in industrial growth and healthcare companies. The firm differentiates itself with its deep, specialized domain and technical expertise and extensive investing experience, having completed more than 250 platform and add-on acquisitions and achieved over 30 realizations, over the last 23 years. Since inception, Arsenal has raised institutional investment funds totaling more than $10 billion. The firm's current Fund VI focuses on investments in businesses with proven technologies and solutions positioned to deliver high performance and value-add to their customers, while its smaller Growth Fund executes a similar strategy in the same markets but pursues investments in next generation, emerging technology businesses poised to apply innovation to generate very high growth.